Pierre Dönnes

Looking forward to the #AdolRheum22 symposium today. I will talk about the use of AI and ML in rheumatic disease.

SciCross is part of the “Biomedical AI-driven data analytics” (BIO-AID) part of this 51 million sek research funding. mynewsdesk.com/se/his/pressre… (in Swedish only)

“Nightswimming deserves a quiet night....” #aftersauna #seasidecamper #mittÅåå instagram.com/p/Bz3wMNuIRJrg…

Flight rescheduled, ending up at a the EGG London AI conference instead. Great talks so far! #EGGLDN2019 #AI #ML

New paper! #infliximab #adalimumab #rheumatoidarthritis #ABIRISK #immunogenicity linkedin.com/feed/update/ur…

New paper on immunogenicity risk in MS patients treated with Interferon beta published in JCI Insight, scicross.com/2018/06/16/imm…. #immunogenicity #MS #ABIRISK

New publication on on protein de-immunization, together with Harvard Medical school and the University of Tubingen. #immunogenicity #FVIII #computationalimmunology scicross.com/2018/05/02/dua…

Nice work from the ABIRISK consortium #abirisk #immunogenicity @SciCross twitter.com/SciCross/statu…

Innovativa startups våren 2017 - Vinnova. Nice to be on that list! vinnova.se/sv/misc/menyer…

I'll be there. Check out "An Evening w/ Hjalmar Winbladh + Startup Matchmaking 2017" eventbrite.com/e/an-evening-w… @Eventbrite

New paper from the ABIRISK consortium dx.doi.org/10.1371/journa… #abirisk @IMI_JU #immunogenicity

Looking forward to two days of #NLSdays in Stockholm. #personalizedmedicine @DataVergeTDA @SciCross #immunogenicity

Schysst start-up atmosfär på @timberyarduk. Koffeinet behövs också. #caffeineaddict.

CNN: 11 startups to bet on in 2015 cnn.it/19zlMnD

Getting ready for venture capital days in Gothenburg #Connect2capital.

So proud to be from Sweden: Experience the power of a bookbook™: youtu.be/MOXQo7nURs0 via @YouTube